medigraphic.com
SPANISH

Revista Homeostasis

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 2

<< Back Next >>

rev homeostasis 2023; 5 (2)

Infecciones de vías urinarias en el embarazo, revisión de la literatura

Mejía RJL, Contreras RKV, Valero RAD, Del Pelayo PM, Tawney SC
Full text How to cite this article

Language: Spanish
References: 37
Page:
PDF size: 551.28 Kb.


Key words:

Urinary tract infections, Pregnancy, asymptomatic bacteriuria, cystitis, pyelonephritis.

ABSTRACT

The urinary tract infections (UTIs) are one of the most common pregnancy complications, and are considered the main cause of obstetric consultation. The clinical types of UTIs can be distinguished as asymptomatic bacteriuria, cystitis, and pyelonephritis. Pregnancy-induced changes that lead to urine stasis are the main causative factor of urinary tract colonization by pathogens, Escherichia Coli is the most common. Patients with untreated or inadequately treated infections are at higher risk of developing pyelonephritis, which can lead to major maternal and fetal complications. Therefore, unlike nonpregnant women, all UTIs during pregnancy require antimicrobial treatment, even when asymptomatic. In some patients, prophylactic treatment in addition to non-pharmacological preventive measures are needed. The objective of this article is to know through a critical review of the literature the clinical significance, diagnosis and treatment of urinary tract infections in pregnant patients and their most common clinical presentations.


REFERENCES

  1. Lockwood C, Copel JA, Dugoff L, Louis J, Moore TR, Silver RM, et al. Bacterial and Parasitic Infections in Pregnancy. In: Creasy & Resnik's maternal-fetal medicine: Principles and practice. 9th ed. Philadelphia, PA: Elsevier; 2023: 879-880.

  2. Partin AW, Peters C, Kavoussi LR, Dmochowski RR, Wein AJ, Campbell MF, et al. Campbell-Walsh Urology 12th edition review. Philadelphia: Elsevier; 2020.

  3. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. 2019; 2019 (11). Disponible en: http://dx.doi.org/10.1002/14651858.CD000490.pub4

  4. Barcelona FMF. Infecciones urinarias Y gestación [Internet]. Medicina Fetal Barcelona. Disponible en: https://portal.medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/infecciones-urinarias-y-gestacion.html

  5. Raya CAZ, Contreras JGS, Gómez Alonso C, Chacón Valladares P. Perfil epidemiológico de adolescentes embarazadas adscritas a una unidad demedicina familiar en [Internet]. Disponible en: https://www.medigraphic.com/pdfs/atefam/af-2018/af182c.pdf

  6. Díaz EC. Prevalencia de Infecciones de Vías Urinarias en Embarazadas, en la unidad de Medicina Familiar No. 11 de Playa del Carmen, Quintana Roo. 2018.

  7. Zúñiga-Martínez M. D, López-Herrera K, Vértiz-Hernández Á. A, Loyola-Leyva A, , Terán-Figueroa Y. Prevalencia de infecciones de vías urinarias en el embarazo y factores asociados en mujeres atendidas en un centro de salud de San Luis Potosí, México. Investigación y Ciencia [Internet]. 2019;27(77):47-55. Recuperado de: https://www.redalyc.org/articulo.oa?id=67459697006

  8. Sierra-Díaz E, Hernández-Ríos CJ, Bravo-Cuellar A. Antibiotic resistance: Microbiological profile of urinary tract infections in Mexico. Cirugía y Cirujanos. 2019;87(2). Disponible en: http://dx.doi.org/10.24875/CIRU.18000494

  9. Navarro A, Sison JM, Puno R, Quizon T, Manio LJ, Gopez J, et al. Reducing the incidence of pregnancy-related urinary tract infection by improving the knowledge and preventive practices of pregnant women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019;241:88–93. Disponible en: http://dx.doi.org/10.1016/j.ejogrb.2019.08.018

  10. Rubio Duran, M. (2017). Cranberry zur Therapie und Prophylaxe von Harnwegsinfekten – was bringt es wirklich? Deutscher Ärzteverlag, 93(11), 439–442. /7986D6C3790849B7B6B8CCC15D048993_ebm_cranberry_1_original.pdf

  11. Plüddemann A. Can drinking more water prevent urinary tract infections? the evidence says yes. BMJ Evidence-Based Medicine. 2019;24(5):191–2. Disponible en: http://dx.doi.org/10.1136/bmjebm-2018-111143

  12. Kraus D. Viel Wasser Trinken Beugt Harnwegsinfekten vor. gynäkologie + geburtshilfe. 2018;23(6):10–. Disponible en: http://dx.doi.org/10.1007/s15013-018-1585-9

  13. Scott AM, Clark J, Mar CD, Glasziou P. Increased fluid intake to prevent urinary tract infections: Systematic review and meta-analysis. British Journal of GeneralPractice. 2020;70(692). Disponible en: http://dx.doi.org/10.3399/bjgp20X708125

  14. Kalinderi K, Delkos D, Kalinderis M, Athanasiadis A, Kalogiannidis I. Urinary tract infection during pregnancy: Current concepts on a common multifaceted problem. Journal of Obstetrics and Gynaecology. 2018;38(4):448–53.

  15. Guzmán N, García-Perdomo HA. Novedades en el diagnóstico y tratamiento de la infección de tracto urinario en adultos. Revista Mexicana de Urología. 2019Dec30;79(6):1–14.

  16. Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2022) [Internet]. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/Sufu Guideline (2022) - american urological association. American Urological Association; 2022 [Citado 14 Abril 2023]. Disponoble en: https://www.auanet.org/guidelines-and-quality/guidelines/recurrent-uti

  17. Sihra, N., Goodman, A., Zakri, R., Sahai, A., & Malde, S. (2018). Nonantibiotic prevention and management of recurrent urinary tract infection. Nature reviews. Urology, 15(12), 750–776. https://doi.org/10.1038/s41585-018-0106-x.

  18. Caljouw MAA, van den Hout WB, Putter H, Achterberg WP, Cools HJM, Gussekloo J. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc [Internet]. 2014 [citado el 24 de julio de 2023];62(1):103–10. Disponible en: http://dx.doi.org/10.1111/jgs.12593

  19. Epp A, Larochelle A. No. 250-recurrent urinary tract infection. Journal of Obstetrics and Gynaecology Canada. 2017;39(10). Disponible en: https://doi.org/10.1016/j.jogc.2017.08.017

  20. Ochoa-Brust GJ, Fernández AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernández B, Vásquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand Suppl. 2007;86(7):783–787. doi: 10.1080/00016340701273189.

  21. Committee opinion number 279: Prevention of early-onset group B streptococcal disease in newborns.Obstetrics & Gynecology. 2002;100(6):1405–12.

  22. Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, Silver RM, et al. Infecciones maternas y fetales. In: Creasy and Resnik's maternal-fetal medicine: Principles and practice. 8th ed. Philadephia: Elsevier; 2019. p. 862–919.

  23. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. 2019;2019(11). Disponible en: 10.1002/14651858.CD000490.pub4

  24. Politis PA, File TM. Highlights of clinical practice guideline for the management of Asymptomatic Bacteriuria. Infectious Diseases in Clinical Practice. 2019;27(6):308–9. Disponible en: http://dx.doi.org/10.1097/ipc.0000000000000796

  25. Kilpatrick S, Watterberg K, Macones G, Papile L-A. Guidelines for perinatal care. 8th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2017.

  26. GPC: Prevención, abordaje y manejo de bacteriuria asintomática e infección de vías urinarias durante el embarazo. Guía de Práctica Clínica: Evidencias y Recomendaciones. México, CENETEC; 2021 [fecha de consulta]. Disponible en: http://www.cenetec-difusion.com/CMGPC/GPC-SS-831-21/ER.pdf

  27. Overview: Urinary tract infection (lower): Antimicrobial prescribing: Guidance [Internet]. NICE. [Citado el 24 de Abril 2023]. Disponible en: https://www.nice.org.uk/guidance/ng109

  28. de Rossi P, Cimerman S, Truzzi JC, Cunha CA, Mattar R, Martino MD, et al. Joint report of SBI (Brazilian society of infectious diseases), FEBRASGO (brazilian federation of gynecology and obstetrics associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): Recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women. The Brazilian Journal of Infectious Diseases. 2020;24(2):110–9.

  29. Corrales M, Corrales-Acosta E, Corrales-Riveros JG. Which antibiotic for urinary tract infections in pregnancy? A literature review of international guidelines. Journal of Clinical Medicine. 2022;11(23):7226. Disponible en: https://doi.org/10.3390/jcm11237226

  30. Bonkat G, Bartoletti R, Bruyere F, Cai T, Geerlings SE, Koves B, et al. EAU guidelines on urological infections [Internet]. European Association of Urology. 2023 [Citado 14 Abril 2023]. Disponible en: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urological-Infections-2022.pdf

  31. Tangcharoensathien V, Sattayawutthipong W, Kanjanapimai S, Kanpravidth W, Brown R, Sommanustweechai A. Antimicrobial resistance: From global agenda to national strategic plan, Thailand. Bulletin of the World Health Organization. 2017;95(8):599–603. Disponible en: 10.2471/BLT.16.179648

  32. Pasillas Fabian FS, Cremades R, Sandoval Pinto E, Beas Ruiz Velasco C, Hernandez Rios CJ, Sierra-Diaz E. Microbiological profile of urinary tract infections in a tertiary medical facility in Western Mexico: An update. Sci Prog [Internet]. 2021;104(1):368504211000886. Disponible en: http://dx.doi.org/10.1177/00368504211000886

  33. Tumbarello M, Trecarichi EM, Bassetti M, De Rosa FG, Spanu T, Di Meco E, et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother [Internet]. 2011;55(7):3485–90. Disponible en: http://dx.doi.org/10.1128/AAC.00009-11

  34. Mohd Sazlly Lim S, Wong PL, Sulaiman H, Atiya N, Hisham Shunmugam R, Liew SM. Clinical prediction models for ESBL-Enterobacteriaceae colonization or infection: A systematic review. Journal of Hospital Infection. 2019;102(1):8–16. Disponible en: http://dx.doi.org/10.1016/j.jhin.2019.01.012

  35. Jain V, Das V, Agarwal A, Pandey A. Asymptomatic bacteriuria & obstetric outcome following treatment in early versus late pregnancy in north Indian women. Indian J Med Res. 2013 Apr;137(4):753-8. PMID: 23703344; PMCID: PMC3724257.

  36. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis: A meta-analysis. Medicine (Baltimore) [Internet]. 2018;97(36):e12192. Disponible en: http://dx.doi.org/10.1097/MD.0000000000012192

  37. Cohen R, Gutvirtz G, Wainstock T, Sheiner E. Maternal urinary tract infection during pregnancy and long-term infectious morbidity of the offspring. Early Human Development. 2019;136:54–9. Disponible en: https://doi.org/10.1016/j.earlhumdev.2019.07.002




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

rev homeostasis. 2023;5